The Case for Extending Treatment in MRD plus Patients on Venetoclax plus Obinutuzumab Therapy
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
Venetoclax, MRD, CLL14, CLL, therapy continuation
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)